Home » Headlines » Currently Reading:

Morning Headlines 5/1/17

May 1, 2017 Headlines No Comments

Athenahealth (ATHN) Q1 2017 Results – Earnings Call Transcript

Athenahealth shares fall 20 percent in trading Friday following its report of Q1 results. In its earnings call, CFO Karl Stubelis said that lower than anticipated claims and collections volumes, more aggressive sales promotions, and slower on boarding of clients were the primary drivers of revenue falling below expectation.

Meditech 10-Q

Meditech reports Q1 results: revenue remained flat at $117 million, EPS $0. vs. $0.51. Net income has dropped 23 percent compared to the same period last year, while dividends paid  per share has remained level.

Cerner (CERN) Q1 2017 Results – Earnings Call Transcript

On Cerner’s Q1 earnings call, CFO Marc Naughton reports that strong software license sales and technology resale drove its quarterly revenue up 11 percent to $1.26 billion.

U. Health Care CEO Vivian Lee resigns after cancer institute controversy

University of Utah Health Care System CEO Vivan Lee resigns following an incident in which she fired the director of the health system’s cancer institute via email. Lee has also been caught in the fallout from a recent STAT news investigation on NantHealth exposing questionable donations coming from Patrick Soon-Shiong, MD, passing through University of Utah Health Care System, and then almost entirely returning to NantHealth.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links